Individual transcriptomic response to strength training for patients with myotonic dystrophy type 1
Myotonic dystrophy type 1 (DM1), the most common form of adult-onset muscular dystrophy, is caused by a CTG expansion resulting in significant transcriptomic dysregulation that leads to muscle weakness and wasting. While strength training is clinically beneficial in DM1, molecular effects had not be...
Main Authors: | Emily E. Davey, Cécilia Légaré, Lori Planco, Sharon Shaughnessy, Claudia D. Lennon, Marie-Pier Roussel, Hannah K. Shorrock, Man Hung, John Douglas Cleary, Elise Duchesne, J. Andrew Berglund |
---|---|
Format: | Article |
Language: | English |
Published: |
American Society for Clinical investigation
2023-07-01
|
Series: | JCI Insight |
Subjects: | |
Online Access: | https://doi.org/10.1172/jci.insight.163856 |
Similar Items
-
Molecular characterization of myotonic dystrophy fibroblast cell lines for use in small molecule screening
by: Jana R. Jenquin, et al.
Published: (2022-05-01) -
Myotonic Dystrophies: State of the Art of New Therapeutic Developments for the CNS
by: Genevieve Gourdon, et al.
Published: (2017-04-01) -
Congenital Myotonic Dystrophy
by: J Gordon Millichap
Published: (1987-09-01) -
Immortalized human myotonic dystrophy muscle cell lines to assess therapeutic compounds
by: Ludovic Arandel, et al.
Published: (2017-04-01) -
Disturbance of the human gut microbiota in patients with Myotonic Dystrophy type 1
by: Manijeh Mahdavi, et al.
Published: (2024-12-01)